Medical Device News Magazine
HomeNON PROFIT

NON PROFIT

Orthobiologics Show Great Promise for Less Invasive Treatment of Certain Musculoskeletal Conditions

AAOS recognizes the potential orthobiologics could have on the future of musculoskeletal patient care, but recommends the need for additional evidence-based research and education for physicians and clear information for patients.

AAOS Releases New Guidance to Elevate and Simplify Patient-Reported Outcome Measures in Practice

Kurt P. Spindler, MD, FAAOS, AAOS PROMs workgroup chair. "The new AAOS PROMs user guide, scoring tool and other high-quality resources distill knowledge and expertise from a broad range of stakeholders and orthopaedic experts to provide a set of best practices to facilitate an organization's ability to implement and utilize PROMs."

Breast Cancer Patients with Higher BMI More Likely to Experience Heart Damage During Chemotherapy

The study will be presented at the American College of Cardiology (ACC) Latin America 2023 Together with Asociación Costarricense de Cardiología in San Jose, Costa Rica.

Newly Published Society of Interventional Radiology Position Statement Outlines Appropriate Use of Endovascular Management for Treatment of Chronic Iliofemoral Venous Occlusions

While this research proceeds, Society of Interventional Radiology believes that adherence to the statement’s recommendations will enable judicious use of endovascular therapy in a manner that optimizes benefit and minimizes harm.

High Schooler (Rakshith Srinivasan) Empowers Youth with Nonprofit “Unlimited Potential”, Raises $100,000 for Sports Medicine Research and Advocacy

Rakshith Srinivasan, a driven high school student from Eastside Preparatory School, Kirkland, WA, has founded a nonprofit organization called Unlimited Potential (UP). UP is dedicated to generating awareness and fundraising for sports medicine research, aiming to empower children with physical disabilities and chronic health conditions to participate in school sports with ease. Rakshith Srinivasan's passion for sports medicine research and STEM awareness has led him to create UP and make a difference in the lives of young athletes within the community.

City of Hope Researchers to Present New Treatments for Blood, Prostate and Other Cancers at 2023 American Society of Clinical Oncology Annual Meeting

This year's ASCO Annual Meeting highlights the exceptional work City of Hope doctors and scientists are leading with the hope of finding better treatments against a wide range of cancers," said Steven T. Rosen, M.D., City of Hope provost and chief scientific officer, Irell & Manella Cancer Center Director's Distinguished Chair.

Photon-Counting CT Offers Superior Imaging in Babies with Heart Defects

Photon-Counting CT is an emerging imaging technique that counts the exact number and measures the energy of incoming x-ray photons.

Pulmonary Fibrosis Foundation Urges Patients to Use Only FDA-Approved Oxygen Delivery Devices

The statement advises the patient community to use only FDA approved oxygen delivery devices as prescribed by their doctor. Individuals should not purchase an oxygen supply device without a prescription from a healthcare provider because doing so may lead to serious health problems. In addition, non-FDA approved oxygen delivery systems may not reliably deliver oxygen.

Beltone Celebrates Roberta Miller’s 60th Anniversary; To be Honored with Lifetime Achievement Award from the International Hearing Society

Gitte Aabo, CEO of GN Hearing (Beltone’s parent company) remarked, “Throughout her career in Beltone, Roberta Miller has fully demonstrated the values Listen, Transform and Challenge, which are the three pillars for our culture. By her genuine care and interest in others, she is a great example of how to bring people closer to one another from an external as well as internal point of view – congratulations, Roberta you are an excellent role model.”

Gilda’s Club Twin Cities Launches Oncology-Focused Initiative to Reach Medically Underserved Communities Via FCC’s Affordable Connectivity Program

“It’s estimated that 34,380 people will be diagnosed with cancer this year across Minnesota. Through this first-of-its-kind initiative, we can reach even more people impacted by cancer with valuable resources that can help contribute to improved outcomes,” said Katherine Todd, DNP, MBA, RN, Gilda’s Club Twin Cities executive director. “We’re proud to be the first of several CSC network partners to embrace this novel program to grow community and to deliver social and emotional support to those who otherwise may not have access.”
spot_imgspot_img

Recent News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”